| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$128,063 ) |
| | 2025 | 2022 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLZ | BROOKLYN | NY | 11201-5301 | KINGS | USA | R01AI132614 | Development of Novel MetAP2 inhibitors as potential therapeutics for Microsporidiosis | 000 | 5 | NIH | 10/29/2024 | -$128,063 |
|
| Issue Date FY: 2024 ( Subtotal = -$237,126 ) |
| | 2024 | 2023 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R21DA055229 | Social Determinants of SUD Treatment Outcomes in a Vulnerable Population | 000 | 2 | NIH | 3/14/2024 | -$237,126 |
|
| Issue Date FY: 2023 ( Subtotal = $31,877 ) |
| | 2023 | 2023 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R21DA055229 | Social Determinants of SUD Treatment Outcomes in a Vulnerable Population | 000 | 2 | NIH | 5/31/2023 | $237,127 |
| | 2023 | 2022 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | U01FD006930 | Elucidating Fundamental Principles of Dermal Pharmacokinetics via Microdialysis | 000 | 3 | FDA | 12/23/2022 | $0 |
| | 2023 | 2020 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R21AA027374 | Receptor Specific Retinoids Probes to Study the Brain Damage Caused byDevelopmental Alcohol Exposure | 000 | 2 | NIH | 11/16/2022 | $0 |
| | 2023 | 2020 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R21AA027374 | Receptor Specific Retinoids Probes to Study the Brain Damage Caused byDevelopmental Alcohol Exposure | 001 | 2 | NIH | 9/18/2023 | -$10,957 |
| | 2023 | 2020 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R21AA027374 | Receptor Specific Retinoids Probes to Study the Brain Damage Caused byDevelopmental Alcohol Exposure | 002 | 2 | NIH | 9/18/2023 | -$194,293 |
| | 2023 | 2018 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R15CA216070 | MTA1- targeted strategies for prostate cancer management | 000 | 1 | NIH | 9/20/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $614,128 ) |
| | 2022 | 2022 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R01AI132614 | Development of Novel MetAP2 inhibitors as potential therapeutics for Microsporidiosis | 000 | 5 | NIH | 3/28/2022 | $401,250 |
| | 2022 | 2022 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R21DA055229 | Social Determinants of SUD Treatment Outcomes in a Vulnerable Population | 000 | 1 | NIH | 5/31/2022 | $212,878 |
| | 2022 | 2022 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | U01FD006930 | Elucidating Fundamental Principles of Dermal Pharmacokinetics via Microdialysis | 000 | 3 | FDA | 8/18/2022 | $0 |
| | 2022 | 2020 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R15CA216070 | MTA1- targeted strategies for prostate cancer management | 001 | 1 | NIH | 3/24/2022 | $0 |
| | 2022 | 2018 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R15CA216070 | MTA1- targeted strategies for prostate cancer management | 000 | 1 | NIH | 3/23/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $592,616 ) |
| | 2021 | 2021 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R01AI132614 | Development of Novel MetAP2 inhibitors as potential therapeutics for Microsporidiosis | 001 | 4 | NIH | 6/29/2021 | $390,001 |
| | 2021 | 2021 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | U01FD006930 | Elucidating Fundamental Principles of Dermal Pharmacokinetics via Microdialysis | 000 | 2 | FDA | 6/29/2021 | $250,000 |
| | 2021 | 2021 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R01AI132614 | Development of Novel MetAP2 inhibitors as potential therapeutics for Microsporidiosis | 000 | 4 | NIH | 4/1/2021 | $401,250 |
| | 2021 | 2020 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R13GM136098 | Annual Conference on Understanding Interventions that Broaden Participation in Science | 000 | 1 | NIH | 2/7/2021 | -$1 |
| | 2021 | 2018 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | U01FD005680 | Adaptive Statistical Methods for Category Specific Release Testing of Drug Products | 000 | 3 | FDA | 10/14/2020 | -$448,634 |
| | 2021 | 2018 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | U01FD005680 | Adaptive Statistical Methods for Category Specific Release Testing of Drug Products | 001 | 3 | FDA | 10/21/2020 | $0 |
| | 2021 | 2017 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | T36GM102000 | Understanding Intervention that Broaden Participation in Research Careers | 000 | 5 | NIH | 2/4/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,878,703 ) |
| | 2020 | 2020 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R21AA027374 | Receptor Specific Retinoids Probes to Study the Brain Damage Caused byDevelopmental Alcohol Exposure | 002 | 2 | NIH | 8/17/2020 | $222,584 |
| | 2020 | 2020 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R21AA027374 | Receptor Specific Retinoids Probes to Study the Brain Damage Caused byDevelopmental Alcohol Exposure | 000 | 2 | NIH | 8/3/2020 | $194,293 |
| | 2020 | 2020 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | U01FD006930 | Elucidating Fundamental Principles of Dermal Pharmacokinetics via Microdialysis | 000 | 1 | FDA | 6/25/2020 | $500,000 |
| | 2020 | 2020 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R15CA216070 | MTA1- targeted strategies for prostate cancer management | 000 | 1 | NIH | 9/9/2020 | $37,850 |
| | 2020 | 2020 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R21AA027374 | Receptor Specific Retinoids Probes to Study the Brain Damage Caused byDevelopmental Alcohol Exposure | 004 | 2 | NIH | 9/11/2020 | $225,649 |
| | 2020 | 2020 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R01AI132614 | Development of Novel MetAP2 inhibitors as potential therapeutics for Microsporidiosis | 003 | 3 | NIH | 9/17/2020 | $226,113 |
| | 2020 | 2020 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R01AI132614 | Development of Novel MetAP2 inhibitors as potential therapeutics for Microsporidiosis | 001 | 3 | NIH | 7/10/2020 | $414,750 |
| | 2020 | 2020 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R13GM136098 | Annual Conference on Understanding Interventions that Broaden Participation in Science | 001 | 1 | NIH | 9/10/2020 | -$605,332 |
| | 2020 | 2020 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R13GM136098 | Annual Conference on Understanding Interventions that Broaden Participation in Science | 000 | 1 | NIH | 2/5/2020 | $663,300 |
| | 2020 | 2017 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | U01FD005862 | Benchmark of dermis microdialysis to assess bioequivalence of dermatological topical products. | 001 | 2 | FDA | 5/28/2020 | -$504 |
| | 2020 | 2017 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | U01FD005862 | Benchmark of dermis microdialysis to assess bioequivalence of dermatological topical products. | 000 | 2 | FDA | 5/4/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = -$53,319 ) |
| | 2019 | 2018 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | U01FD005680 | Adaptive Statistical Methods for Category Specific Release Testing of Drug Products | 000 | 3 | FDA | 6/14/2019 | $0 |
| | 2019 | 2017 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | U01FD005862 | Benchmark of dermis microdialysis to assess bioequivalence of dermatological topical products. | 001 | 2 | FDA | 9/11/2019 | $0 |
| | 2019 | 2017 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | T36GM102000 | Understanding Intervention that Broaden Participation in Research Careers | 000 | 5 | NIH | 8/9/2019 | $0 |
| | 2019 | 2017 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | U01FD005862 | Benchmark of dermis microdialysis to assess bioequivalence of dermatological topical products. | 000 | 2 | FDA | 8/30/2019 | $0 |
| | 2019 | 2016 | LONG ISLAND UNIVERSITY | 1 University Plaza | BROOKLYN | NY | 11201-5301 | KINGS | USA | G0230557 | Behavioral Health Workforce Education and Training for Professionals and Paraprofessionals | 04 | 1 | HRSA | 5/13/2019 | -$53,319 |
|
| Issue Date FY: 2018 ( Subtotal = $1,369,534 ) |
| | 2018 | 2018 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | R15CA216070 | MTA1- targeted strategies for prostate cancer management | 000 | 1 | NIH | 5/28/2018 | $420,900 |
| | 2018 | 2018 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | U01FD005680 | Adaptive Statistical Methods for Category Specific Release Testing of Drug Products | 000 | 3 | FDA | 5/8/2018 | $500,000 |
| | 2018 | 2018 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | U01FD005680 | Adaptive Statistical Methods for Category Specific Release Testing of Drug Products | 001 | 3 | FDA | 8/29/2018 | $448,634 |
| | 2018 | 2017 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | U01FD005862 | Benchmark of dermis microdialysis to assess bioequivalence of dermatological topical products. | 001 | 2 | FDA | 12/8/2017 | $0 |
| | 2018 | 2017 | LONG ISLAND UNIVERSITY | 1 UNIVERSITY PLAZA | BROOKLYN | NY | 11201-5301 | KINGS | USA | U01FD005862 | Benchmark of dermis microdialysis to assess bioequivalence of dermatological topical products. | 000 | 2 | FDA | 12/5/2017 | $0 |
| | 2018 | 2016 | LONG ISLAND UNIVERSITY | 700 Northern Blvd | Greenvale | NY | 11548-1319 | NASSAU | USA | G02HP30557 | Behavioral Health Workforce Education and Training for Professionals and Paraprofessionals | 03 | 1 | HRSA | 3/26/2018 | $0 |
|
|
